Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Sero-prevalence and epidemiology of peste des petits ruminants in Libya.

Dayhum A, Sharif M, Eldaghayes I, Kammon A, Calistri P, Danzetta ML, Di Sabatino D, Petrini A, Ferrari G, Grazioli S, Pezzoni G, Brocchi E.

Transbound Emerg Dis. 2018 Feb;65(1):e48-e54. doi: 10.1111/tbed.12670. Epub 2017 Jul 12.

PMID:
28703449
2.

Hepatitis E Virus: A Cross-Sectional Serological and Virological Study in Pigs and Humans at Zoonotic Risk within a High-Density Pig Farming Area.

Caruso C, Peletto S, Rosamilia A, Modesto P, Chiavacci L, Sona B, Balsamelli F, Ghisetti V, Acutis PL, Pezzoni G, Brocchi E, Vitale N, Masoero L.

Transbound Emerg Dis. 2017 Oct;64(5):1443-1453. doi: 10.1111/tbed.12533. Epub 2016 Jul 5.

PMID:
27380833
3.

Differential Biological Activities of Swine Interferon-α Subtypes.

Zanotti C, Razzuoli E, Crooke H, Soule O, Pezzoni G, Ferraris M, Ferrari A, Amadori M.

J Interferon Cytokine Res. 2015 Dec;35(12):990-1002. doi: 10.1089/jir.2015.0076. Epub 2015 Oct 8.

4.

Comparison of three in-house ELISAs for the detection of hepatitis E virus infection in pigs under field conditions.

Pezzoni G, Caminiti A, Stercoli L, Grazioli S, Galletti G, Santi A, Tamba M, Brocchi E.

J Virol Methods. 2014 Oct;207:95-103. doi: 10.1016/j.jviromet.2014.06.025. Epub 2014 Jul 7.

PMID:
25010789
5.

Expression of a truncated hepatitis E virus capsid protein in the protozoan organism Leishmania tarentolae and its application in a serological assay.

Baechlein C, Meemken D, Pezzoni G, Engemann C, Grummer B.

J Virol Methods. 2013 Oct;193(1):238-43. doi: 10.1016/j.jviromet.2013.05.018. Epub 2013 Jun 5.

PMID:
23747546
6.

[Significant two-weeks clinical efficacy of an association between Massaciuccoli peat and sodium chloride water of Undulna Thermae measured on gynoid lipodystrophy in a group of overweight female].

Rondanelli M, Opizzi A, Perna S, Faliva MA, Buonocore D, Pezzoni G, Michelotti A, Marchetti R, Marzatico F.

Ann Ig. 2012 Sep-Oct;24(5):369-78. Italian.

PMID:
23193893
7.

Recombinant ELISA using baculovirus-expressed VP2 for detection of antibodies against canine parvovirus.

Elia G, Desario C, Pezzoni G, Camero M, Brocchi E, Decaro N, Martella V, Buonavoglia C.

J Virol Methods. 2012 Sep;184(1-2):98-102. doi: 10.1016/j.jviromet.2012.05.025. Epub 2012 Jun 1.

PMID:
22664182
8.

Novel bis-platinum complexes endowed with an improved pharmacological profile.

Gatti L, Perego P, Leone R, Apostoli P, Carenini N, Corna E, Allievi C, Bastrup U, De Munari S, Di Giovine S, Nicoli P, Grugni M, Natangelo M, Pardi G, Pezzoni G, Singer JW, Zunino F.

Mol Pharm. 2010 Feb 1;7(1):207-16. doi: 10.1021/mp900211j.

PMID:
19919086
9.

CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.

Evison BJ, Bilardi RA, Chiu FC, Pezzoni G, Phillips DR, Cutts SM.

Nucleic Acids Res. 2009 Oct;37(19):6355-70. doi: 10.1093/nar/gkp700. Epub 2009 Aug 31.

10.

Formaldehyde-activated Pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doublets.

Evison BJ, Chiu F, Pezzoni G, Phillips DR, Cutts SM.

Mol Pharmacol. 2008 Jul;74(1):184-94. doi: 10.1124/mol.108.045625. Epub 2008 Apr 15.

11.

Pixantrone (BBR2778) reduces the severity of experimental autoimmune myasthenia gravis in Lewis rats.

Ubiali F, Nava S, Nessi V, Longhi R, Pezzoni G, Capobianco R, Mantegazza R, Antozzi C, Baggi F.

J Immunol. 2008 Feb 15;180(4):2696-703.

12.

Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.

Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP.

J Med Chem. 2008 Feb 28;51(4):1068-72. doi: 10.1021/jm7010589. Epub 2008 Feb 5.

PMID:
18247547
13.

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.

Piva R, Ruggeri B, Williams M, Costa G, Tamagno I, Ferrero D, Giai V, Coscia M, Peola S, Massaia M, Pezzoni G, Allievi C, Pescalli N, Cassin M, di Giovine S, Nicoli P, de Feudis P, Strepponi I, Roato I, Ferracini R, Bussolati B, Camussi G, Jones-Bolin S, Hunter K, Zhao H, Neri A, Palumbo A, Berkers C, Ovaa H, Bernareggi A, Inghirami G.

Blood. 2008 Mar 1;111(5):2765-75. Epub 2007 Dec 5.

14.

Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate.

Chipman SD, Oldham FB, Pezzoni G, Singer JW.

Int J Nanomedicine. 2006;1(4):375-83. Review.

15.

Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition.

Sissi C, Lucatello L, Paul Krapcho A, Maloney DJ, Boxer MB, Camarasa MV, Pezzoni G, Menta E, Palumbo M.

Bioorg Med Chem. 2007 Jan 1;15(1):555-62. Epub 2006 Oct 10.

PMID:
17035038
16.

Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies.

Springett GM, Bonham L, Hummer A, Linkov I, Misra D, Ma C, Pezzoni G, Di Giovine S, Singer J, Kawasaki H, Spriggs D, Soslow R, Dupont J.

Cancer Res. 2005 Oct 15;65(20):9415-25. Erratum in: Cancer Res. 2005 Dec 15;65(24):11785.

17.

Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.

Sava G, Zorzet S, Turrin C, Vita F, Soranzo M, Zabucchi G, Cocchietto M, Bergamo A, DiGiovine S, Pezzoni G, Sartor L, Garbisa S.

Clin Cancer Res. 2003 May;9(5):1898-905.

18.

Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity.

Beggiolin G, Crippa L, Menta E, Manzotti C, Cavalletti E, Pezzoni G, Torriani D, Randisi E, Cavagnoli R, Sala F, Giuliani FC, Spinelli S.

Tumori. 2001 Nov-Dec;87(6):407-16.

PMID:
11989596
19.

Identification of phenyl-pyridine-2-carboxylic acid derivatives as novel cell cycle inhibitors with increased selectivity for cancer cells.

Berthel SJ, Marks IM, Yin X, Mischke SG, Orzechowski L, Pezzoni G, Sala F, Vassilev LT.

Anticancer Drugs. 2002 Apr;13(4):359-66.

PMID:
11984081
20.

Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor.

Cavaletti G, Pezzoni G, Pisano C, Oggioni N, Sala F, Zoia C, Ferrarese C, Marmiroli P, Tredici G.

Neurosci Lett. 2002 Apr 5;322(2):103-6.

PMID:
11958854
21.

Cell-based screening approach for antitumor drug leads which exploits sensitivity differences between normal and cancer cells: identification of two novel cell-cycle inhibitors.

Vassilev LT, Kazmer S, Marks IM, Pezzoni G, Sala F, Mischke SG, Foley L, Berthel SJ.

Anticancer Drug Des. 2001 Feb;16(1):7-17.

PMID:
11762646
22.

A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.

Supino R, Polizzi D, Pavesi R, Pratesi G, Guano F, Capranico G, Palumbo M, Sissi C, Richter S, Beggiolin G, Menta E, Pezzoni G, Spinelli S, Torriani D, Carenini N, Dal Bo L, Facchinetti F, Tortoreto M, Zunino F.

Oncology. 2001;61(3):234-42.

PMID:
11574780
23.

A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.

Perego P, De Cesare M, De Isabella P, Carenini N, Beggiolin G, Pezzoni G, Palumbo M, Tartaglia L, Pratesi G, Pisano C, Carminati P, Scheffer GL, Zunino F.

Cancer Res. 2001 Aug 15;61(16):6034-7.

24.

Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from berberine.

Colombo ML, Bugatti C, Mossa A, Pescalli N, Piazzoni L, Pezzoni G, Menta E, Spinelli S, Johnson F, Gupta RC, Dasaradhi L.

Farmaco. 2001 May-Jul;56(5-7):403-9.

PMID:
11482767
25.

Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study.

Cavaletti G, Oggioni N, Sala F, Pezzoni G, Cavalletti E, Marmiroli P, Petruccioli MG, Frattola L, Tredici G.

Toxicol Lett. 2000 Dec 20;118(1-2):103-7.

PMID:
11137315
26.

BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G, Zunino F.

Clin Cancer Res. 2000 Jul;6(7):2626-34.

27.

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.

Pratesi G, Perego P, Polizzi D, Righetti SC, Supino R, Caserini C, Manzotti C, Giuliani FC, Pezzoni G, Tognella S, Spinelli S, Farrell N, Zunino F.

Br J Cancer. 1999 Aug;80(12):1912-9.

28.

A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system.

Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N, Zunino F.

Mol Pharmacol. 1999 Mar;55(3):528-34. Erratum in: Mol Pharmacol 1999 Jun;55(6):1108.

29.

Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles).

Krapcho AP, Menta E, Oliva A, Di Domenico R, Fiocchi L, Maresch ME, Gallagher CE, Hacker MP, Beggiolin G, Giuliani FC, Pezzoni G, Spinelli S.

J Med Chem. 1998 Dec 31;41(27):5429-44.

PMID:
9876113
30.

Reduced glutathione protects against cisplatin-induced neurotoxicity in rats.

Hamers FP, Brakkee JH, Cavalletti E, Tedeschi M, Marmonti L, Pezzoni G, Neijt JP, Gispen WH.

Cancer Res. 1993 Feb 1;53(3):544-9.

31.

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.

Ripamonti M, Pezzoni G, Pesenti E, Pastori A, Farao M, Bargiotti A, Suarato A, Spreafico F, Grandi M.

Br J Cancer. 1992 May;65(5):703-7.

32.

Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.

Pezzoni G, Grandi M, Biasoli G, Capolongo L, Ballinari D, Giuliani FC, Barbieri B, Pastori A, Pesenti E, Mongelli N, et al.

Br J Cancer. 1991 Dec;64(6):1047-50.

33.
34.

Novel anthracycline analogs.

Grandi M, Pezzoni G, Ballinari D, Capolongo L, Suarato A, Bargiotti A, Faiardi D, Spreafico F.

Cancer Treat Rev. 1990 Sep;17(2-3):133-8. Review. No abstract available.

PMID:
2272029
35.

In vitro and in vivo studies of poly-L-lysine as inducer of Friend leukemic cells differentiation.

Supino R, Gibelli N, Nano R, Pezzoni G, Zunino F.

Tumori. 1987 Oct 31;73(5):431-6.

PMID:
3479855
36.
37.

Growth characteristics of human colorectal and non-small cell lung tumors xenografted into nude mice: possible correlation with prognosis.

Pratesi G, Pezzoni G, Giardini R, Doci R, Valente M, Parmiani G.

Tumori. 1986 Aug 31;72(4):351-6.

PMID:
3020752
38.

A study on the possible involvement of nonlinear mechanism of light absorption by HpD with Nd:YAG laser.

Marchesini R, Melloni E, Pezzoni G, Savi G, Zunino F, Docchio F, Fava G.

Lasers Surg Med. 1986;6(3):323-7.

PMID:
2942743
39.

Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug.

Pratesi G, Savi G, Pezzoni G, Bellini O, Penco S, Tinelli S, Zunino F.

Br J Cancer. 1985 Dec;52(6):841-8.

40.

NMU-1, a new transplantable mouse lung tumor: biological and chemosensitivity properties in vivo.

Pratesi G, Pezzoni G, Parmiani G.

Cancer Treat Rep. 1985 Feb;69(2):219-21.

PMID:
3971393
41.

Prevention of cyclophosphamide-induced urotoxicity by reduced glutathione and its effect on acute toxicity and antitumor activity of the alkylating agent.

Tofanetti O, Cavalletti E, Besati A, Pratesi G, Pezzoni G, Zunino F.

Cancer Chemother Pharmacol. 1985;14(3):188-93.

PMID:
3995681
42.

A comparison of efficacy of photoradiation therapy and other conventional treatment modalities on experimental MS-2 sarcoma.

Pezzoni G, Savi G, Melloni E, Marchesini R, Fava G, Locati L, Zunino F.

Cancer Lett. 1984 Dec;25(2):209-16.

PMID:
6239681
43.

Hyperthermal effects in phototherapy with hematoporphyrin derivative sensitization.

Melloni E, Marchesini R, Emanuelli H, Fava G, Locati L, Pezzoni G, Savi G, Zunino F.

Tumori. 1984 Aug 31;70(4):321-5.

PMID:
6474582
44.

Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriers.

Zunino F, Savi G, Giuliani F, Gambetta R, Supino R, Tinelli S, Pezzoni G.

Eur J Cancer Clin Oncol. 1984 Mar;20(3):421-5.

PMID:
6538501
45.

An enzyme-histochemical approach to the study of the human bone-marrow stroma.

Burgio VL, Magrini U, Ciardelli L, Pezzoni G.

Acta Haematol. 1984;71(2):73-80.

PMID:
6421058
46.

Effectiveness of laser photoradiation therapy following hematoporphyrin derivative administration in the experimental MS-2 tumor model.

Zunino F, Marchesini R, Melloni E, Savi G, Pezzoni G, Locati L, Fava G.

Tumori. 1983 Aug 31;69(4):305-8.

PMID:
6623653

Supplemental Content

Loading ...
Support Center